Limits the substitution of abuse-deterrent analgesic opioid drug products for analgesic opioids lacking such technology

This bill requires health insurance plans to cover at least one abuse-deterrent opioid pain medication per active ingredient, ensuring patients can access FDA-approved options designed to reduce misuse. It limits cost-sharing (like copays) for these drugs to the same level as non-abuse-deterrent opioids, preventing insurers from increasing patient costs to comply. The law also prohibits prior authorization rules from forcing prescribers to use non-abuse-deterrent opioids to access safer alternatives. It directly affects patients prescribed opioids, insurers, and healthcare providers by mandating equitable coverage for abuse-deterrent formulations. The policy applies to all opioid analgesics approved by the FDA with abuse-deterrent labeling.